Virtual Reality for Cognitive Impairment in Hemodialysis
Launched by UNIVERSITY OF CAMPANIA LUIGI VANVITELLI · Dec 12, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into whether using virtual reality (VR) can help improve cognitive function in people undergoing hemodialysis, a treatment for kidney failure. The researchers want to find out if it is easy for patients to participate in VR training during their dialysis sessions and if they find it helpful and enjoyable. Participants will be divided into two groups: one group will use VR games designed to boost memory and attention for 30 minutes during their dialysis three times a week for 12 weeks, while the other group will just receive standard dialysis without any VR.
To be eligible for this study, participants must be adults aged 18 to 75 who have been on hemodialysis for at least three months and can understand Italian. They should be able to use the VR headset and follow instructions. However, people with severe cognitive issues, certain medical conditions, or difficulties using the VR system will not be included. This trial is not yet recruiting participants, but it aims to understand the potential benefits of VR in this setting, which could lead to better cognitive health for patients on dialysis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult participants aged 18 years or older and less than or equal to 75 years of age
- • Receiving haemodialysis treatment for kidney failure for at least 90 days (permanent reduction in kidney function below an estimated glomerular filtration rate of 15 mL/minute per 1.73 m2)
- • Able to provide written and informed consent
- • Able to use the immersive virtual reality headset and follow instructions with sufficient motor, visual and auditory function to interact with the intervention
- • Able to speak and understand Italian language
- Exclusion Criteria:
- • Severe cognitive impairment or psychiatric diseases leading to inability to follow instructions and use the virtual reality headset
- • Significant nystagmus and/or vertigo leading to inability to tolerate the virtual reality headset
- • Insufficient motor function to use the virtual reality system
- • Hearing or visual disability
- • Advanced or uncompensated chronic diseases unrelated to kidney failure (e.g. advanced cancer, heart failure, lung diseases with poor oxygen saturation)
- • Other neurological diseases (ictus, Alzheimer's or other forms of dementia)
- • Persistent pain or itch or who using opioids that may interfere with the tests or any other condition that the clinician may judge as influencing the results
About University Of Campania Luigi Vanvitelli
The University of Campania Luigi Vanvitelli is a distinguished academic institution located in Italy, renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive expertise in biomedical sciences to conduct innovative studies that address critical health challenges. With a focus on ethical standards and patient safety, the university collaborates with various healthcare professionals and research entities to facilitate groundbreaking clinical investigations, ultimately contributing to the development of new therapies and enhancing medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bari, Ba, Italy
Naples, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported